SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trillium Therapeutics
TRIL 20.36+2.0%Nov 26 2:56 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (126)12/18/2017 3:11:08 PM
From: semi_infinite   Read Replies (1) of 294
 
I had 3 scenarios before buying some (1) complete failure due to SAEs - prob guess 0.33, (2) continuation of 3 yards and a cloud of dust - prob guess 0.66 (3) conclusive miraculous results - prob guess 1/100.

We ended up a little better than (2) because of skin lesion results, CR on combo and no SAEs. I see some negative comments because of small N and that $500K CAR-T drugs conclusively show better response. Both true. The stock moved from 4.9 to 13.3 in 2 months so I would say some good news has been credited. My POV was that some mean reversion would occur and I acted accordingly. I have no idea what the proper mean is but somewhere between 8 and 9 (arithmetic and geometric means) are as good as any. Short term traders rule for now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext